Index Entries

1985 Results
TitleIS Publication Date
An observational and Mendelian randomisation study on vitamin D and COVID-19 risk in UK BiobankSeptember 14, 2021
An observational study of breakthrough SARS-CoV-2 Delta variant infections among vaccinated healthcare workers in VietnamSeptember 29, 2021
An open debate on SARS-CoV-2’s proximal origin is long overdueFebruary 7, 2021
An outbreak caused by the SARS-CoV-2 Delta variant (B.1.617.2) in a secondary care hospital in Finland, May 2021July 1, 2021
An overview of the anti-SARS-CoV-2 properties of Artemisia annua, its antiviral action, protein-associated mechanisms, and repurposing for COVID-19 treatmentJuly 22, 2021
An overview of the MATH+, I-MASK+ and I-RECOVER Protocols — A Guide to the Management of COVID-19
An Update on COVID-19 Vaccine Induced Thrombotic Thrombocytopenia Syndrome and Some Management RecommendationsAugust 18, 2021
Anakinra for severe forms of COVID-19: a cohort studyMay 29, 2020
Analysis of COVID-19 vaccine death reports from the Vaccine Adverse Events Reporting System (VAERS) Database Interim: Results and AnalysisJune 2021
Analysis of Neurological Adverse Events Reported in VigiBase From COVID-19 VaccinesJanuary 18, 2022
Analysis of the initial lot of the CDC 2019-Novel Coronavirus (2019-nCoV) real-time RT-PCR diagnostic panelDecember 15, 2021
Analysis of Thromboembolic and Thrombocytopenic Events After the AZD1222, BNT162b2, and MRNA-1273 COVID-19 Vaccines in 3 Nordic CountriesJune 14, 2022
Analysis of vitamin D level among asymptomatic and critically ill COVID?19 patients and its correlation with infammatory markers
Anaphylaxis to Pfizer/BioNTech mRNA COVID-19 Vaccine in a Patient With Clinically Confirmed PEG AllergySeptember 28, 2021
Anaphylaxis-Induced Acute Coronary Syndrome Following Covid-19 mRNA-LNP Vaccination: Mechanisms and Therapeutic ApproachesOctober 1, 2024
Anecdotals (documentary)December 2022
Anthem BCBS Medicaid - COVID-19 Vaccine Provider Incentive programOctober 21, 2021
Anthony Fauci emails acquired by FOIA request
Anthony Fauci on C-SPAN’s Washington JournalOctober 11, 2004
Anti-recoverin Antibody-Associated Post-acute COVID Vaccination Syndrome After BNT162b2 in HLA-B27-Positive Spondylarthritis: A Case ReportAugust 14, 2024
Anti-SARS-CoV-2 Receptor-Binding Domain Antibody Evolution after mRNA VaccinationOctober 7, 2021
Anti-science case study: COVID-19 vaccines’ effectiveness and safety exaggeratedMay 23, 2024
Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaeniaJuly 7, 2021
Antibody levels decrease after two doses of Pfizer vaccine – studyOctober 7, 2021
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care WorkersFebruary 11, 2021
Antibody-dependent enhancement
Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapiesSeptember 9, 2020
Antigenic minimalism of SARS-CoV-2 is linked to surges in COVID-19 community transmission and vaccine breakthrough infectionsMay 31, 2021
Antiviral Effect of Budesonide against SARS-CoV-2July 20, 2021
Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trialJune 18, 2021
Antiviral treatments [Molnupiravir] lead to the rapid accrual of hundreds of SARS-CoV-2 mutations in immunocompromised patients
Antiviral, virucidal and antioxidant properties of Artemisia annua against SARS-CoV-2October 11, 2023
Aphasia seven days after second dose of an mRNA-based SARS-CoV-2 vaccineJune 24, 2021
Apparent risks of postural orthostatic tachycardia syndrome diagnoses after COVID-19 vaccination and SARS-Cov-2 InfectionDecember 12, 2022
Appendix 1: estimation of number needed to vaccinate to prevent a COVID-19 hospitalisation for primary vaccination, booster vaccination (3rd dose), autumn 2022 and spring 2023 booster for those newly in a risk groupJanuary 25, 2023
APPENDIX 2.2: Cumulative and Interval Summary Tabulation of Serious and Non-Serious Adverse Reactions from Post-Marketing Data SourcesJune 21, 2022
Approval letter: Biologics License Application (BLA) Approval for BioNTech (Pfizer) Manufacturing GmbHAugust 23, 2021
Are COVID-19 Vaccines in Pregnancy as Safe and Effective as the Medical Industrial Complex Claim? Part IFebruary 8, 2025
Are COVID-19 Vaccines in Pregnancy as Safe and Effective as the U.S. Government, Medical Organizations, and Pharmaceutical Industry Claim? Part IIJuly 1, 2024
Are Face Masks Effective? The Evidence.Published July 2020, updated September 2023
Are Lockdowns Effective in Managing Pandemics?July 29, 2022
Arrhythmias after COVID-19 Vaccination: Have We Left All Stones Unturned?June 20, 2023
Artemisia annua L. and Its Derivatives: Their Antiviral Effects on COVID-19 and Possible MechanismsJanuary 24, 2022
Assessing Case Fatality on Cases of Thrombosis with Concurrent Thrombocytopenia Following COVID-19 Vaccine AstraZeneca (Vaxzevria) in the United Kingdom: A Review of Spontaneously Reported DataAugust 4, 2022
Assessing mandatory stay-at-home and business closure effects on the spread of COVID-19January 5, 2021
Assessment of cardiac adverse events following COVID‑19 vaccination by speckle tracking echocardiographyMay 13, 2024
Assessment of Myocardial 18F-FDG Uptake at PET/CT in Asymptomatic SARS-CoV-2–vaccinated and Nonvaccinated PatientsSeptember 19, 2023
Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational studyMarch 27, 2021
Assessment report: COVID-19 Vaccine ModernaMarch 11, 2021
Association between COVID-19 Vaccination and Neuropsychiatric ConditionsApril 14, 2025